XORTX Therapeutics (NASDAQ:XRTX) shares fell around 8% Thursday morning after the pharma firm priced a securities offering to raise $1.5M in gross proceeds.
The company entered into securities purchase agreements with institutional investors for the purchase and sale of 810,810 common
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.